4//SEC Filing
VINCENT RICHARD G 4
Accession 0001209191-23-052015
CIK 0001260990other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:59 PM ET
Size
31.5 KB
Accession
0001209191-23-052015
Insider Transaction Report
Form 4
VINCENT RICHARD G
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option
2023-10-02−35,120→ 0 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (35,120 underlying) - Disposition to Issuer
Stock Option
2023-10-02−28,750→ 0 totalExercise: $1.04Exp: 2032-07-28→ Common Stock (28,750 underlying) - Disposition to Issuer
Stock Option
2023-10-02−75,000→ 0 totalExercise: $5.76Exp: 2029-09-12→ Common Stock (75,000 underlying) - Disposition to Issuer
Stock Option
2023-10-02−280,000→ 0 totalExercise: $7.05Exp: 2031-02-11→ Common Stock (280,000 underlying) - Disposition to Issuer
Stock Option
2023-10-02−109,579→ 0 totalExercise: $1.94Exp: 2032-01-20→ Common Stock (109,579 underlying) - Award
Stock Option
2023-10-02+280,000→ 280,000 totalExercise: $0.31Exp: 2031-02-11→ Common Stock (280,000 underlying) - Award
Stock Option
2023-10-02+210,000→ 210,000 totalExercise: $0.31Exp: 2033-02-21→ Common Stock (210,000 underlying) - Disposition to Issuer
Stock Option
2023-10-02−210,000→ 0 totalExercise: $0.96Exp: 2033-02-21→ Common Stock (210,000 underlying) - Award
Stock Option
2023-10-02+75,000→ 75,000 totalExercise: $0.31Exp: 2029-09-12→ Common Stock (75,000 underlying) - Award
Stock Option
2023-10-02+35,120→ 35,120 totalExercise: $0.31Exp: 2030-03-17→ Common Stock (35,120 underlying) - Award
Stock Option
2023-10-02+109,597→ 109,597 totalExercise: $0.31Exp: 2032-01-20→ Common Stock (109,597 underlying) - Award
Stock Option
2023-10-02+28,750→ 28,750 totalExercise: $0.31Exp: 2032-07-28→ Common Stock (28,750 underlying)
Footnotes (8)
- [F1]The shares subject to the option (the "Option Shares") are fully vested.
- [F2]On October 2, 2023, the Issuer repriced the option. Except as described further in footnotes 7 and 8, all other terms of the option remain unchanged.
- [F3]25% of the Option Shares vested on February 11, 2022, and the remaining Option Shares vest in 36 equal monthly installments thereafter, subject to the recipient's continued service.
- [F4]25% of the Option Shares vested on January 20, 2023, and the remaining Option Shares vest in 36 equal monthly installments thereafter, subject to the recipient's continued service.
- [F5]50% of the Option Shares vested on July 3, 2023, and 50% of the Option Shares vest on January 3, 2024, subject to the recipient's continued service. All of the Option Shares vest in the event of a Change in Control (as defined in the Issuer's 2019 Incentive Award Plan).
- [F6]25% of the Option Shares vest on February 21, 2024, and the remaining Option Shares vest in 36 equal monthly installments thereafter, subject to the recipient's continued service.
- [F7]The exercise price of the option is $0.31 per share, representing the fair market value per share of the common stock on the grant date; provided that the exercise price will be increased to the original exercise price before repricing if, prior to October 2, 2024: (i) recipient's employment or service terminates, other than due to death, disability, or circumstances giving rise to severance under the recipient's employment agreement (a "Qualifying Termination"); or (ii) the option is exercised.
- [F8]The exercise price of the option is $0.31 per share, representing the fair market value per share of the common stock on the grant date; provided that the exercise price will be increased to the original exercise price before repricing if, prior to April 2, 2025: (i) recipient's employment or service terminates, other than due to a Qualifying Termination; or (ii) the option is exercised.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001269341
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:59 PM ET
- Size
- 31.5 KB